MFDS approves Korea-developed surgical robot system ‘Revo-I’
‘Revo-I,’ a surgical robot system developed for the first time in Korea, was approved from the Ministry of Food and Drug Safety(MFDS) on the 3rd of August.
The approved ‘Revo-I’ is a system to help surgeons to perform endoscopic surgeries like removing a gall bladder or prostate gland, by insert...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
